Literature DB >> 30580579

Visualization of Blood Glucose Fluctuations Using Continuous Glucose Monitoring in Patients Undergoing Hemodialysis.

Katsuhito Mori1, Masanori Emoto2, Masanori Abe3, Masaaki Inaba1,2.   

Abstract

Entities:  

Keywords:  continuous glucose monitoring; diabetic kidney disease; hemodialysis; teneligliptin; type 2 diabetes

Mesh:

Substances:

Year:  2018        PMID: 30580579      PMCID: PMC6399784          DOI: 10.1177/1932296818818429

Source DB:  PubMed          Journal:  J Diabetes Sci Technol        ISSN: 1932-2968


× No keyword cloud information.
  6 in total

1.  Glycated albumin is a better glycemic indicator than glycated hemoglobin values in hemodialysis patients with diabetes: effect of anemia and erythropoietin injection.

Authors:  Masaaki Inaba; Senji Okuno; Yasuro Kumeda; Shinsuke Yamada; Yasuo Imanishi; Tsutomu Tabata; Mikio Okamura; Shigeki Okada; Tomoyuki Yamakawa; Eiji Ishimura; Yoshiki Nishizawa
Journal:  J Am Soc Nephrol       Date:  2007-01-31       Impact factor: 10.121

Review 2.  Haemodialysis-induced hypoglycaemia and glycaemic disarrays.

Authors:  Masanori Abe; Kamyar Kalantar-Zadeh
Journal:  Nat Rev Nephrol       Date:  2015-04-07       Impact factor: 28.314

3.  Improved glycemic control with teneligliptin in patients with type 2 diabetes mellitus on hemodialysis: Evaluation by continuous glucose monitoring.

Authors:  Noritsugu Wada; Katsuhito Mori; Chie Nakagawa; Jun Sawa; Yasuro Kumeda; Tetsuo Shoji; Masanori Emoto; Masaaki Inaba
Journal:  J Diabetes Complications       Date:  2015-07-03       Impact factor: 2.852

Review 4.  Antidiabetic agents in patients with chronic kidney disease and end-stage renal disease on dialysis: metabolism and clinical practice.

Authors:  Masanori Abe; Kazuyoshi Okada; Masayoshi Soma
Journal:  Curr Drug Metab       Date:  2011-01       Impact factor: 3.731

5.  Diabetic kidney disease: a report from an ADA Consensus Conference.

Authors:  Katherine R Tuttle; George L Bakris; Rudolf W Bilous; Jane L Chiang; Ian H de Boer; Jordi Goldstein-Fuchs; Irl B Hirsch; Kamyar Kalantar-Zadeh; Andrew S Narva; Sankar D Navaneethan; Joshua J Neumiller; Uptal D Patel; Robert E Ratner; Adam T Whaley-Connell; Mark E Molitch
Journal:  Diabetes Care       Date:  2014-10       Impact factor: 19.112

6.  Linagliptin monotherapy compared with voglibose monotherapy in patients with type 2 diabetes undergoing hemodialysis: a 12-week randomized trial.

Authors:  Katsuhito Mori; Masanori Emoto; Tetsuo Shoji; Masaaki Inaba
Journal:  BMJ Open Diabetes Res Care       Date:  2016-07-19
  6 in total
  5 in total

Review 1.  Continuous glucose monitoring in patients with type 2 diabetes on hemodialysis.

Authors:  Maurizio Gallieni; Cristina De Salvo; Maria Elena Lunati; Antonio Rossi; Francesca D'Addio; Ida Pastore; Gianmarco Sabiu; Roberta Miglio; Gian Vincenzo Zuccotti; Paolo Fiorina
Journal:  Acta Diabetol       Date:  2021-03-20       Impact factor: 4.280

2.  Promotion of Adropin Expression by Hyperglycemia Is Associated with STAT3 Activation in Diabetic Rats.

Authors:  Feng Yu Kuo; Kai-Chun Cheng; Yingxiao Li; Juei-Tang Cheng; Cheng-Chia Tsai
Journal:  Diabetes Metab Syndr Obes       Date:  2020-06-29       Impact factor: 3.168

3.  Blood Glucose Fluctuation in Older Adults with Diabetes Mellitus and End-Stage Renal Disease on Maintenance Hemodialysis: An Observational Study.

Authors:  Jinzhu Li; Ruiqin Zhang; Zhen Wu; Jiayu Guo; Zhiying Wang; Shuhui Li; Chunlin Li; Guang Yang; Xiaoling Cheng
Journal:  Diabetes Ther       Date:  2022-06-11       Impact factor: 3.595

Review 4.  Maintenance of Skeletal Muscle to Counteract Sarcopenia in Patients with Advanced Chronic Kidney Disease and Especially Those Undergoing Hemodialysis.

Authors:  Katsuhito Mori
Journal:  Nutrients       Date:  2021-05-02       Impact factor: 5.717

Review 5.  Molecular Mechanisms of Glucose Fluctuations on Diabetic Complications.

Authors:  Zhen-Ye Zhang; Ling-Feng Miao; Ling-Ling Qian; Ning Wang; Miao-Miao Qi; Yu-Min Zhang; Shi-Peng Dang; Ying Wu; Ru-Xing Wang
Journal:  Front Endocrinol (Lausanne)       Date:  2019-09-18       Impact factor: 5.555

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.